AxoGen, Inc. (AXGN) vs UFP Technologies, Inc. (UFPT)
AxoGen, Inc. and UFP Technologies, Inc. are both Medical Devices companies. AxoGen, Inc. and UFP Technologies, Inc. are of similar size ($2.5B and $2.3B). AxoGen, Inc. has negative trailing earnings, so its P/E is not meaningful; UFP Technologies, Inc. trades at 31.6×. AxoGen, Inc. grew revenue faster over the last twelve months: 23.6% against 7.32%. UFP Technologies, Inc. has the higher net margin (11.5% vs −13.4%) and the higher return on invested capital (10.3% vs −4.99%). Across the 20 metrics below, UFP Technologies, Inc. leads on 16 and AxoGen, Inc. on 4.
Valuation
Profitability
| Metric | AXGN | UFPT | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.56% | 28.50% | 56.01% |
| Operating margin | (5.12%) | 15.25% | (15.03%) |
| Net margin | (13.36%) | 11.45% | (20.40%) |
| Free cash flow margin | 2.59% | 9.74% | (7.24%) |
| Return on equity | (18.21%) | 17.05% | (15.32%) |
| Return on assets | (13.15%) | 10.98% | (19.72%) |
| Return on invested capital | (4.99%) | 10.29% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack